Hpv

HPV and meningococcal vaccination coverage among adolescents aged 13 to 17 years in the United States continues to improve, although geographical disparities persist, according to findings published in MMWR.

Health care providers should begin offering routine HPV vaccination to children as young as age 9 years in order to increase rates of on-time administration, according to an updated American Cancer Society guideline.

El Paso, Texas, used community-based interventions, clinical referrals and partnership referrals through schools and organizations to improve HPV vaccination rates among adolescents, researchers reported.

An educational comic book about HPV and HPV vaccine improved college students’ attitudes about completing the vaccination process and their intention to do so within one year.

The combination of pembrolizumab and GX-188E, a DNA vaccine targeting HPV types 16 and 18, conferred high response rates compared with pembrolizumab alone among a cohort of women with advanced, inoperable or metastatic cervical cancer, according to results of an interim analysis presented at the virtual American Association for Cancer Research Annual Meeting.

Healio spoke with experts in oncology, internal medicine, cardiovascular medicine, rheumatology and endocrinology about the long-term effects of cancer treatment and how to help manage care for cancer survivors. It was the top story in hematology/oncology last week.

Today is International HPV Awareness Day.

One of the top stories in hematology/oncology last week was about a recent FDA report that concluded there is “insufficient evidence” to link cellphone radiation exposure to cancer.

The NCI awarded a 5-year, $8.3 million research grant to Weill Cornell Medicine, Moffitt Cancer Center and Universidade de Sao Paulo in Brazil to investigate strategies to prevent HPV-related cancers among individuals with HIV.

Rates of late-stage head and neck cancer increased in the United States between 2004 and 2015, propelled by rising incidence among white men, according to study results published in Cancer.